Connaught Laboratories Limited
Records under this name other than patents Connaught Laboratories Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Connaught Laboratories Limited
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,656,472 | Multi oligosaccharide glycoconjugate bacterial meningitis vaccines Formerly held Term ended Term ended Dec 22, 2020 · From the USPTO record | Term ended | Term ended Dec 22, 2020 | From the USPTO record |
| US 6,228,423 | Biodegradable targetable microparticle delivery system Term ended Term ended Feb 11, 2020 · From the USPTO record | Term ended | Term ended Feb 11, 2020 | From the USPTO record |
| US 6,235,523 | Vectors for DNA immunization against cervical cancer Term ended Term ended Sep 3, 2019 · From the USPTO record | Term ended | Term ended Sep 3, 2019 | From the USPTO record |
| US 6,140,082 | Expression of gene products from genetically manipulated strains of bordetella Term ended Term ended Aug 16, 2019 · From the USPTO record | Term ended | Term ended Aug 16, 2019 | From the USPTO record |
| US 6,391,313 | Multi-component vaccine to protect against disease caused by Haemophilus influenzae and Moraxella catarrhalis Formerly held Term ended Term ended Jul 15, 2019 · From the USPTO record | Term ended | Term ended Jul 15, 2019 | From the USPTO record |
| US 6,482,928 | Fab′-epitope complex from HIV-1 cross-neutralizing monoclonal antibody 2F5 Formerly held Term ended Term ended Apr 13, 2019 · From the USPTO record | Term ended | Term ended Apr 13, 2019 | From the USPTO record |
| US 6,368,589 | Use of autologous promoters to express gene products in Bordetella Formerly held Term ended Ended no later than Apr 9, 2019 · From the USPTO record | Term ended | Ended no later than Apr 9, 2019 | From the USPTO record |
| US 6,083,925 | Nucleic acid respiratory syncytial virus vaccines Term ended Term ended Mar 5, 2019 · From the USPTO record | Term ended | Term ended Mar 5, 2019 | From the USPTO record |
| US 6,017,537 | Formyl methionyl peptide vaccine adjuvant Term ended Term ended Dec 18, 2018 · From the USPTO record | Term ended | Term ended Dec 18, 2018 | From the USPTO record |
| US 6,329,512 | Immunogenic conjugate molecules Formerly held Term ended Term ended Dec 11, 2018 · From the USPTO record | Term ended | Term ended Dec 11, 2018 | From the USPTO record |